Potential health effects from non‐specific stimulation of the immune function in early age: The example of BCG vaccination
暂无分享,去创建一个
Yves St-Pierre | Marie-Claude Rousseau | Y. St-Pierre | M. Parent | Marie-Elise Parent | M. Rousseau
[1] J Siemiatycki,et al. Bacille Calmette-Guérin Vaccination and Incidence of IDDM in Montreal, Canada , 1997, Diabetes Care.
[2] D. Strachan,et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. , 2001, American journal of public health.
[3] Donna Spiegelman,et al. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] Annette Pfahlberg,et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. , 2002, The Journal of investigative dermatology.
[5] P. Grosjean,et al. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Gie,et al. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children , 2005, Allergy.
[7] T. Annus,et al. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination , 2004, Allergy.
[8] G. Walraven,et al. Absence of association between delayed type hypersensitivity to tuberculin and atopy in children in The Gambia , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[9] B. Niggemann,et al. Messages from the German Multicentre Allergy Study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[10] G. Hems,et al. B.C.G. AND LEUKÆMIA , 1971 .
[11] I. Annesi-Maesano,et al. Does childhood immunization against infectious diseases protect from the development of atopic disease? , 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[12] Shaheen,et al. Early BCG vaccination and reduction in atopy in Guinea‐Bissau , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[13] Jean Weissenbach,et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.
[14] D. Snider,et al. Efficacy of BCG vaccination in prevention of cancer: an update. , 1978, Journal of the National Cancer Institute.
[15] U. Wahn,et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. , 1998, The Journal of allergy and clinical immunology.
[16] Ethan M. Shevach,et al. CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness , 2002, The Journal of experimental medicine.
[17] Sergio Romagnani,et al. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? , 2004, Immunology.
[18] M. Blennerhassett,et al. The increasing prevalence of Crohn's disease in industrialized societies: the price of progress? , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[19] J. Holloway,et al. Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.
[20] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[21] D. Umetsu,et al. Regulatory T cells control the development of allergic disease and asthma. , 2003, The Journal of allergy and clinical immunology.
[22] G. Dahlquist,et al. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM , 1995, Diabetologia.
[23] O. Stutman. Chemical carcinogenesis in nude mice: comparison between nude mice from homozygous matings and heterozygous matings and effect of age and carcinogen dose. , 1979, Journal of the National Cancer Institute.
[24] S. Pek,et al. Prevention of Insulitis and Diabetes Onset by Treatment With Complete Freund's Adjuvant in NOD Mice , 1991, Diabetes.
[25] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[26] S. Salvi,et al. Could administration of bacille Calmette‐Guérin vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated? , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[27] A. Buist,et al. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults , 2000, Thorax.
[28] M. Greaves. Infection, immune responses and the aetiology of childhood leukaemia , 2006, Nature Reviews Cancer.
[29] I. Fortier,et al. Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia , 2000, British Journal of Cancer.
[30] S. Rosenthal. Cancer precursors and their control by BCG. , 1986, Developments in biological standardization.
[31] Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[32] M. Abreu,et al. Defects in mucosal immunity leading to Crohn's disease , 2005, Immunological reviews.
[33] M. Jacobsen,et al. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation. , 2004, The Journal of urology.
[34] A. Pahari,et al. BCG, tuberculin skin-test results and asthma prevalence in school children in North London. , 2002, Indian pediatrics.
[35] N. Petrovsky,et al. Prevention of Autoimmune Diabetes through Immunostimulation with Q Fever Complement‐Fixing Antigen , 2003, Annals of the New York Academy of Sciences.
[36] Mph Dr. Robert S. Sandler MD,et al. Childhood infections and the risk of inflammatory bowel disease , 2005, Digestive Diseases and Sciences.
[37] R. Greenstein. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. , 2003, The Lancet. Infectious diseases.
[38] B. Niggemann,et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study , 2001, BMJ : British Medical Journal.
[39] C. Akdis,et al. Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.
[40] M. Melbye,et al. Age at bacille Calmette–Guérin vaccination and risk of allergy and asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[41] É. Lerebours,et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study , 2005, Gut.
[42] G. Le Gros,et al. Development of an asthma vaccine: research into BCG. , 2000, Drugs.
[43] A. Frappier,et al. B.C.G. vaccination and leukaemia mortality. , 1970, Lancet.
[44] L. Cohn. Mucus in chronic airway diseases: sorting out the sticky details. , 2006, The Journal of clinical investigation.
[45] G. Rook,et al. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae , 1998, Immunology.
[46] L Davignon,et al. B.C.G. VACCINATION AND LEUKqMIA MORTALITY , 1971 .
[47] B. Björkstén,et al. Immune deviation and the hygiene hypothesis: A review of the epidemiological evidence , 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[48] C. Huber,et al. Immmunotherapy of cancer: from vision to standard clinical practice , 2004, Journal of Cancer Research and Clinical Oncology.
[49] M. Yılmaz,et al. Correlation between atopic diseases and tuberculin responses , 2000, Allergy.
[50] G. Draper,et al. B.C.G. vaccination and leukaemia mortality. , 1971, Lancet.
[51] C. Hawrylowicz,et al. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. , 2002, The Journal of allergy and clinical immunology.
[52] A. Gulsvik,et al. Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults , 2002, Allergy.
[53] L. Kinlen,et al. Evidence from population mixing in British New Towns 1946-85 of an infective basis for childhood leukaemia , 1990, The Lancet.
[54] O. Gefeller,et al. Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. , 2003, European journal of cancer.
[55] M. Langman,et al. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. , 1987, Scandinavian journal of gastroenterology.
[56] G. Pershagen,et al. Early BCG vaccination and development of atopy , 1997, The Lancet.
[57] M. Melbye,et al. BCG vaccination and risk of atopy. , 2003, JAMA.
[58] S. Franceschi,et al. Medical history and risk of Hodgkin's and non‐Hodgkin's lymphomas , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[59] U. Wahn,et al. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Guérin-vaccinated and nonvaccinated children. , 2001, Pediatrics.
[60] U. Wahn,et al. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[61] T. Haahtela,et al. Immunization and atopy: possible implications of ethnicity. , 2004, The Journal of allergy and clinical immunology.
[62] E. Sarinho,et al. BCG scar diameter and asthma: a case-control study. , 2000, The Journal of allergy and clinical immunology.
[63] R. Logan,et al. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study , 1998, Gut.
[64] S. Burdach,et al. Reduced expression of transforming growth factor β1 exacerbates pathology in an experimental asthma model , 2005, European journal of immunology.
[65] J. Castro‐Rodriguez,et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. , 2000, The New England journal of medicine.
[66] Shimon Sakaguchi,et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. , 2004, International immunology.
[67] M. Sadelain,et al. Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy , 1990, Diabetes.
[68] M. Sadelain,et al. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. , 1990, Journal of autoimmunity.
[69] G. Comstock. BCG vaccination and cancer. , 1991, Tubercle.
[70] D. Classen,et al. THE TIMING OF PEDIATRIC IMMUNIZATION AND THE RISK OF INSULIN-DEPENDENT DIABETES MELLITUS , 1997 .
[71] G. Comstock,et al. BCG vaccination and the subsequent development of cancer in humans. , 1981, Journal of the National Cancer Institute.
[72] G. Hems,et al. B.C.G. and leukaemia. , 1971, The Lancet.
[73] I. Barlan,et al. Effect of pre‐immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin‐sensitized newborn mice , 1999, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[74] H. Storm,et al. Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis. , 2002, Journal of the National Cancer Institute.
[75] Bhagirath Singh,et al. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. , 1997, Journal of autoimmunity.
[76] J. Satoh,et al. Streptococcal Preparation (OK-432) Inhibits Development of Type I Diabetes in NOD Mice , 1986, Diabetes.
[77] P. Gourdy,et al. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. , 2003, Blood.
[78] J. Palefsky,et al. Immunosuppression and co-infection with HIV , 2003 .
[79] C. Tam,et al. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong , 2001, Thorax.
[80] O. Gefeller,et al. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. , 2005, European journal of cancer.
[81] S. Phipps,et al. A role for eosinophils in airway remodelling in asthma. , 2004, Trends in immunology.
[82] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[83] I. Strannegård,et al. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria , 1998, Allergy.
[84] B. Norlén,et al. 5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group. , 1999, The Journal of urology.
[85] R. Flavell,et al. Transforming growth factor-beta in T-cell biology. , 2002, Nature reviews. Immunology.
[86] N. Høiby,et al. Results of Multiple Diagnostic Tests forMycobacterium avium subsp. paratuberculosis in Patients with Inflammatory Bowel Disease and in Controls , 2000, Journal of Clinical Microbiology.
[87] William D. Lees,et al. Defective acute inflammation in Crohn's disease: a clinical investigation , 2006, The Lancet.
[88] B. Tönshoff,et al. Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipients , 2004, Pediatric Nephrology.
[89] H. Waaler. B.C.G. and leukaemia mortality. , 1970, Lancet.
[90] D. Coggon,et al. Inflammatory bowel disease and domestic hygiene in infancy , 1994, The Lancet.
[91] D. Liggitt,et al. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells , 2004, Nature Immunology.
[92] M. Harada,et al. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. , 1990, Diabetes research and clinical practice.
[93] G. Dahlquist,et al. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination , 1995, Diabetologia.
[94] R. Mitsuyasu,et al. AIDS-related Kaposi's sarcoma: current treatment options, future trends. , 2000, Oncology.
[95] R. Hoover,et al. Risk of cancer in renal-transplant recipients. , 1973, Lancet.
[96] R. Vile. Faculty Opinions recommendation of IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. , 2001 .
[97] C. Sanjeevi,et al. BCG Vaccination and GAD65 and IA‐2 Autoantibodies in Autoimmune Diabetes in Southern India , 2002, Annals of the New York Academy of Sciences.
[98] C. Hawrylowicz,et al. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma , 2005, Nature Reviews Immunology.
[99] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[100] A. Frappier,et al. B.C.G. vaccination and leukemia mortality. , 1970, Lancet.
[101] H Hjalgrim,et al. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. , 2000, Journal of the National Cancer Institute.
[102] P. Sly,et al. TH2‐polarized immunological memory to inhalant allergens in atopies is established during infaney and early childhood , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[103] R. Townley,et al. The effect of BCG vaccine at birth on the development of atopy or allergic disease in young children. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[104] B. Sander,et al. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. , 1995, Immunology.
[105] E. Bonifacio,et al. Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes. , 2005, Diabetes care.
[106] A. Lalvani,et al. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. , 2006, American journal of respiratory and critical care medicine.
[107] E. Seidman,et al. Investigating the Hygiene Hypothesis as a Risk Factor in Pediatric Onset Crohn's Disease: A Case-Control Study , 2006, The American Journal of Gastroenterology.
[108] J. Palefsky,et al. Chapter 6: Immunosuppression and co-infection with HIV. , 2003, Journal of the National Cancer Institute. Monographs.
[109] B. Toelle,et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. , 2003, The Journal of allergy and clinical immunology.
[110] F. Guillén-Grima,et al. BCG Immunization at Birth and Atopic Diseases in a Homogeneous Population of Spanish Schoolchildren , 2005, International Archives of Allergy and Immunology.
[111] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.
[112] The Inverse Association Between Tuberculin Responses and Atopic Disorder , 1997, Science.
[113] M. Barreto,et al. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG , 2004, Allergy.
[114] H. Adami,et al. Perinatal risk factors for inflammatory bowel disease: a case-control study. , 1990, American journal of epidemiology.